国产放疗设备集成应用专家共识——鼻咽癌同质化IMRT设备质量控制篇

doi:10.3760/cma.j.issn.1004-4221.2020.01.001

摘要
图/表
参考文献(20)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要 IMRT设备构成的复杂性和临床放疗精确性的要求,对鼻咽癌IMRT的质量控制提出了极高的要求,合理、可靠、具有针对性的质量控制是精确放疗的必要组成部分。目前中国放疗设备国产化推广应用进展迅速,各单位在放疗设备配置人员组成、质量控制保障能力等方面存在着差距,放疗质量控制难以达到同质化,建立国产放疗设备质控的专家共识,明确质控项目、检测程序、检测条件以及人员资质要求等,能够有力保证各放疗单位质量控制的规范化、同质化,并能确立质量保证的责任、程序、流程、质量管理等,以期每位患者达到最好的放疗。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：国产放疗设备, 鼻咽癌/调强放射疗法, 质量控制, 人员资质

Abstract：The complexity of intensity-modulated radiotherapy (IMRT) equipment and the accuracy of clinical radiotherapy require extremely high standards for the,quality control of IMRT for nasopharyngeal carcinoma. Reasonable, reliable and targeted quality control is an essential part of precise radiotherapy. At present, domestic radiotherapy equipment is developing rapidly. Nevertheless, radiotherapy equipment, personnel composition and quality control significantly differ among hospitals. Therefore, it is difficult to achieve homogeneity in the quality control of radiotherapy. Establishing an expert consensus on the quality control of domestic radiotherapy equipment can clarify the content of quality control, testing procedures, testing conditions and personnel qualification and requirement. It can effectively ensure the standardization and homogeneity of the quality control and establish the responsibility, procedures, processes and quality management of the quality control, aiming to offer the optimal radiotherapy to each patient.

Key words： Domestic radiotherapy equipment Nasopharyngeal neoplasm/intensity-modulated radiotherapy Quality control Personnel qualification

收稿日期: 2019-02-20

基金资助:国家重点研发计划项目(2016YFC0106400)

通讯作者: 孙建国,陆军军医大学第二附属医院肿瘤科;Email:sunjg09@aliyun.com

引用本文:

. 国产放疗设备集成应用专家共识——鼻咽癌同质化IMRT设备质量控制篇[J]. 中华放射肿瘤学杂志, 2020, 29(1): 1-5.

. Consensus on integrated application of domestic radiotherapy equipment-Nasopharyngeal carcinoma homogeneous IMRT:quality control& assurance[J]. Chinese Journal of Radiation Oncology, 2020, 29(1): 1-5.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2020.01.001 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2020/V29/I1/1

[1]梁锌,杨剑,高婷,等. 中国鼻咽癌流行概况[J]. 中国肿瘤,2016,25(11):835-840. DOI:10.11735/j.issn.1004-0242.2016.11. A00.
Laing Z,Yang J,Gao T,et al. Nasopharynx cancer epidemiologyin China[J]. Chin Cancer,2016,25(11):835-840. DOI:10.11735/j.issn.1004-0242.2016.11. A00.
[2]Sun Y,Li WF,Chen NY,et al. Inductionchemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma:a phase 3,multicentre,randomised controlled trial[J]. Lancet Oncol,2016,17(11):1509-1520. DOI:10.1016/S1470-2045(16)30410-7.
[3]Zhang L,Huang Y,Hong S,et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma:a multicentre,randomised,open-label,phase 3 trial[J]. Lancet,2016,388(10054):1883-1892. DOI:10.1016/S0140-6736(16)31388-5.
[4]黄培钰,麦海强,罗东华,等. 局部晚期鼻咽癌诱导加同期化放疗与诱导化放疗的对照研究[J]. 癌症,2009,28(10):1033-1042.
Huang PJ,Mai HQ,Luo DH,et al. Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma[J]. Chin J Cancer, 2009,28(10):1033-1042.
[5]苏胜发,赵充,韩非,等. 鼻咽癌适形IMRT远期疗效分析[J]. 中华肿瘤防治杂志,2013,20(11):853-858.
Su SF,Zhao C,Han F,et al. Long-term outcome of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy[J]. Chin J Cancer Prevent Treat,2013,20(11):853-858.
[6]郎锦义,王培,吴大可,等.2015年中国大陆放疗基本情况调查研究[J]. 中华放射肿瘤学杂志,2016,(6):541-545. DOI:10.3760/cma.j.issn.1001-4221.2016.06.001.
Lang JY,Wang P,Wu DK,et al. An investigation of the basic situation of radiotherapy in mainland China in 2015[J]Chin J Radiat Oncol,2016,(6):541-545. DOI:10.3760/cma.j.issn.1001-4221.2016.06.001.
[7]王宝亭,耿鸿武. 医疗器械蓝皮书中国医疗器械行业发展报告(2018)[M]. 北京:社会科学文献出版社,2018.
Wang BT,Geng HW. Annual report on the development of medical device industry in China[M]. Beijing:Social Sciences Academic Press,2018.
[8]赫捷,王绿化,李晔雄,等. 放疗质量控制基本指南[J]. 中华放射肿瘤学杂志,2018,27(4):335-342. DOI:10.3760/cma.j.issn.1004-4221.2018.04.001.
He J,Wang LH,Li YX,et al. Basic guidelines of quality control for radiotherapy[J]. Chin J Radiat Oncol, 2018,27(4):335-342. DOI:10.3760/cma.j.issn.1004-4221.2018.04.001.
[9]中华人民共和国国家卫生和计划生育委员会. 医疗机构设置规划指导原则(2016-2020年)[J]. 中国实用乡村医生杂志,2017,(2):3-6. DOI:10.3969/j.issn.1672-7185.2017.02.003.
National Health and Family Planning Commission of the People′s Republic of China. Guidelines for medical institution setup planning (2016-2020)[J]. Chin J Pract Rural Doct,2017,(2):3-6. DOI:10.3969/j.issn.1672-7185.2017.02.003.
[10]GB 15213-2016.医用电子加速器性能和试验方法[S].北京:国家质量技术监督局,2016.
GB 15213-2016. Performance and test methods of medical electron accelerators[S]. Beijing:National Bureau of quality and technical supervision,2016.
[11]NCC/T-RT 001-2017.放疗质量控制基本指南[R].马里兰州:国家癌症研究所,2017.
NCC/T-RT 001-2017. Basic guidelines for radiotherapy quality control[R]. Maryland:National cancer institute, 2017.
[12]Commissioning and quality assurance of computerized planning systems for radiation treatment of cancer[R]. Geneva:IAEA,2004.
[13]GB/T 19046-2013.医用电子加速器验收试验和周期检验规程[S].北京:国家质量技术监督局,2013.
GB/T 19046-2013. Code for acceptance test and periodic inspection of medical electron accelerators[S]. Beijing:National bureau of quality and technical supervision,2013.
[14]GB/T 17857-1999.医用放射学术语(放疗、核医学和辐射剂量学设备)[S].北京:国家质量技术监督局,1999.
GB/T 17857-1999. Medical radiology terminology (radiotherapy, nuclear medicine and radiation dosimetry equipment)[S]. Beijing:National bureau of quality and technical supervision,1999.
[15]金献测,谢聪颖. 肿瘤放疗物理质控手册[M]. 北京:科学出版社,2018.
Jin XC,Xie CY. Physical quality control manual for tumor radiotherapy[M]. Beijing:Science press,2018.
[16]Ezzell GA,Burmeister JW,Dogan N,et al. IMRT commissioning:multiple institution planning and dosimetry comparisons,a report from AAPM Task Group 119[J]. Med Phys,2009,36(11):5359-5373. DOI:10.1118/1.3238104.
[17]Molloy JA,Chan G,Markovic A,et al. Quality assurance of U. S.-guided external beam radiotherapy for prostate cancer:report of AAPM Task Group 154[J]. Med Phys,2011,38(2):857-871. DOI:10.1118/1.3531674.
[18]Moyed M,Arthur O,Dimitris M,et al. Tolerance limits and methodologies for IMRT measurement-based verification QA:Recommendations of AAPM Task Group No.218[J]. Med Phys,2018,45(4):52-83. DOI:10.1002/mp.12810.
[19]Klein EE,Hanley J,Bayouth J,et al. Task Group No.142:quality assurance of medical acclerators. Recommendations of AAPM Task Group No.142[J]. Med Phys,2009,36(9):4197-4212. DOI:10.1118/1.3190392.
[20]放疗计划系统的调试:典型外照射技术的测试[R].北京:国家食品药品监督管理总局,2013.
Debugging of radiotherapy planning system:testing of typical external irradiation technology[R]. Beijing:State food and drug aDministration,2013.

[1]	国产放疗设备集成应用专家组, 中华医学会数字医学分会, 重庆市医学会放射肿瘤治疗学专业委员会, 重庆市中西医结合学会肿瘤放疗专委会, 重庆市抗癌协会肿瘤放疗专委会西部放疗协会. 国产放疗设备集成应用专家共识——鼻咽癌同质化IMRT设备篇[J]. 中华放射肿瘤学杂志, 2019, 28(8): 561-565.